Patents by Inventor Joaquin Querol Sastre

Joaquin Querol Sastre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Colony stimulating factor for use in pancreatic or colon cancer treatment
    Patent number: 11020455
    Abstract: There is provided a Colony Stimulating Factor (CSF) as an active ingredient for use in the treatment of colon or pancreatic cancer through an increase in neutrophilia, wherein the Colony Stimulating Factor is selected from the group consisting of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) and Granulocyte Colony Stimulating Factor (G-CSF). The new use for these two recombinant proteins represents a new treatment option for two of the most frequent forms of cancer.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: June 1, 2021
    Assignee: ENDOR TECHNOLOGIES, S.L
    Inventors: Laura Vivero Sánchez, Luciano Sobrevals Amieva, Rafael Miñana Prieto, Judith Sendra Cuadal, Joaquín Querol Sastre
  • COLONY STIMULATING FACTOR FOR USE IN PANCREATIC OR COLON CANCER TREATMENT
    Publication number: 20180214517
    Abstract: There is provided a Colony Stimulating Factor (CSF) as an active ingredient for use in the treatment of colon or pancreatic cancer through an increase in neutrophilia, wherein the Colony Stimulating Factor is selected from the group consisting of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) and Granulocyte Colony Stimulating Factor (G-CSF). The new use for these two recombinant proteins represents a new treatment option for two of the most frequent forms of cancer.
    Type: Application
    Filed: July 28, 2016
    Publication date: August 2, 2018
    Inventors: Laura VIVERO SÁNCHEZ, Luciano SOBREVALS AMIEVA, Rafael MIÑANA PRIETO, Judith SENDRA CUADAL, Joaquín QUEROL SASTRE
  • Conjugate of hyaluronic acid for cosmetic treatment and preparation method
    Patent number: 8901080
    Abstract: This invention discloses a new conjugate compound that comprises at least one HA oligomer derivatized through one thiolated linker, whereby it binds to at least one metal nanoparticle, such as, for example, a gold nanoparticle. Moreover, it discloses methods of obtaining it, as well as the use thereof in a cosmetic treatment, and cosmetic compositions that contain them.
    Type: Grant
    Filed: January 5, 2009
    Date of Patent: December 2, 2014
    Assignee: Endor Nanotechnologies, S.L.
    Inventors: Marc Ramis Castelltort, Isaac Ojea Jimenez, Joaquin Querol Sastre
  • CONJUGATE OF HYALURONIC ACID FOR COSMETIC TREATMENT AND PREPARATION METHOD
    Publication number: 20110144030
    Abstract: This invention discloses a new conjugate compound that comprises at least one HA oligomer derivatised through one thiolated linker, whereby it binds to at least one metal nanoparticle, such as, for example, a gold nanoparticle. Moreover, it discloses methods of obtaining it, as well as the use thereof in a cosmetic treatment, and cosmetic compositions that contain them.
    Type: Application
    Filed: January 5, 2009
    Publication date: June 16, 2011
    Inventors: Marc Ramis Castelltort, Isaac Ojea Jimenez, Joaquin Querol Sastre